Palvella Therapeutics Balance Sheet (2013-2026) | PVLA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	91.80M	34.90M	117.76M	83.74M	54.26M	48.42M	38.63M	39.74M	54.90M	44.80M	7.35M	6.25M	14.54M	14.21M	83.60M	75.63M	70.43M	63.57M	57.98M	206.39M
Short-term Investments (Quarter)				16.53M	26.68M	21.40M	20.53M	8.64M	9.94M	11.92M	8.97M									55.46M
Cash & Current Investments (Quarter)	91.80M	34.90M	117.76M	100.27M	80.94M	69.82M	59.17M	48.38M	64.84M	56.72M	16.32M	6.25M	14.54M	14.21M	83.60M	75.63M	70.43M	63.57M	57.98M	261.85M
Receivables - Net (Quarter)	17.00M	17.00M	3.31M	1.64M	1.26M	0.83M	5.81M	1.05M	0.95M	1.04M		1.84M	1.49M	0.37M	0.36M
Receivables - Other (Quarter)							4.77M				2.33M	3.07M	3.05M
Receivables (Quarter)	17.00M	17.00M	3.31M	1.64M	1.26M	0.83M	10.58M	1.05M	0.95M	1.04M	2.33M	4.91M	4.53M	0.37M	0.36M
Prepaid Assets (Quarter)	5.77M	5.95M	6.55M	9.84M	8.70M	7.91M	3.21M	11.07M	10.64M	9.15M	0.20M	2.97M	0.65M	0.28M	2.30M	1.83M	1.34M	1.15M	1.00M	1.38M
Current Assets (Quarter)	127.67M	137.65M	127.62M	111.75M	90.90M	78.56M	73.42M	60.51M	66.47M	59.09M	7.55M				88.23M	79.44M	73.75M	66.94M	58.99M	263.23M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	20.37M	19.61M	19.12M	18.85M	17.43M	15.90M	16.99M	16.71M	16.16M
Long-Term Investments (Quarter)					20.29M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)	3.12M	2.95M	2.90M	2.67M	2.36M	1.31M	1.37M	1.25M	1.09M	0.29M
Non-Current Assets (Quarter)	27.36M	26.54M	25.93M	25.37M	23.41M	20.60M	22.07M	21.75M	21.07M	0.29M									0.57M	0.53M
Assets (Quarter)	155.03M	164.18M	153.56M	137.12M	114.31M	99.16M	95.49M	82.26M	87.54M	59.38M	7.55M	29.50M	25.05M	20.52M	88.23M	79.44M	73.75M	66.94M	59.56M	263.76M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	2.31M	19.68M	8.61M	14.07M	10.79M	3.64M	4.15M	5.83M	7.60M	2.82M	0.94M	1.52M	0.97M	0.80M	4.59M	4.44M	4.56M	3.48M	4.59M	5.44M
Payables (Quarter)	2.31M	19.68M	8.61M	14.07M	10.79M	3.64M	4.15M	5.83M	7.60M	2.82M	0.94M	1.52M	0.97M	0.80M	4.59M	4.44M	4.56M	3.48M	4.59M	5.44M
Accumulated Expenses (Quarter)	16.08M	19.68M	16.84M			3.25M	10.75M	1.68M	2.12M	12.76M	1.42M	6.01M	5.38M	3.45M	5.47M	2.56M	0.79M	4.62M	4.35M	0.68M
Other Accumulated Expenses (Quarter)	0.17M	0.22M	0.39M	0.64M	0.61M	0.58M	0.48M	0.59M	0.50M	0.57M	0.12M	0.34M	1.01M	1.03M	0.40M	0.82M	0.93M	1.05M	1.20M	0.96M
Short term Debt (Quarter)															1.98M	1.98M	1.98M	2.22M	2.20M
Current Leases (Quarter)			1.05M			0.83M	0.86M	0.89M	0.91M	12.29M									0.20M	0.21M
Current Deferred Revenue (Quarter)	25.54M	26.45M	25.12M	20.91M	22.86M	0.70M	20.82M	26.69M	4.70M	3.50M
Curent Deferred Tax Liability (Quarter)
Total Current Liabilities (Quarter)	43.93M	49.70M	50.56M	39.48M	35.55M	33.52M	36.58M	42.88M	34.37M	28.87M	2.36M	7.53M	6.35M	4.25M	12.04M	8.98M	9.62M	10.31M	11.34M	9.12M
Non-Current Liabilities
Non-Current Debt (Quarter)
Non-Current Deffered Revenue (Quarter)	49.42M	46.19M	38.40M	30.82M		18.48M	18.73M	11.73M	0.76M
Preferred Stock Liabilities (Quarter)							70.60M				70.60M
Operating Leases (Quarter)	14.96M	15.48M	13.84M	13.36M	13.25M	11.39M	12.24M	13.09M	12.83M										0.43M	0.38M
Other Non-Current Liabilities (Quarter)											1.01M				1.65M	1.72M	1.84M	1.92M	2.04M	2.16M
Total Non-Current Liabilities (Quarter)	108.31M	110.33M	102.81M				67.56M		47.05M		10.41M				11.90M	22.14M	14.50M	16.00M	17.80M	19.80M
Total Liabilities (Quarter)	108.31M	110.33M	102.81M	83.67M	69.94M	63.40M	67.56M	66.80M	47.05M	28.87M	11.43M	106.37M	105.88M	107.93M	25.63M	23.86M	25.97M	28.25M	31.58M	31.45M
Shareholder's Equity
Total Debt (Quarter)															1.98M	1.98M	1.98M	2.22M	2.20M
Common Equity (Quarter)	46.72M	53.85M	50.76M	53.45M	44.37M	317.49M	-93.78M	15.46M	40.50M	30.51M	-74.48M	-76.87M	-80.83M	-87.40M	62.61M	55.58M	47.78M	38.68M	27.98M	232.31M
Shareholder's Equity (Quarter)	46.72M	53.85M	50.76M	53.45M	44.37M		-93.78M	15.46M	40.50M	30.51M	-74.48M	-76.87M	-80.83M	-87.40M	62.61M	55.58M	47.78M	38.68M	27.98M	232.31M
Liabilities and Shareholders Equity (Quarter)	155.03M	164.18M	153.56M	137.12M	114.31M	99.16M	95.49M	82.26M	87.54M	59.38M	7.55M	29.50M	25.05M	20.52M	88.23M	79.44M	73.75M	66.94M	59.56M	263.76M
Retained Earnings (Quarter)	-231.10M	0.62M	-257.14M	0.95M	-272.60M	-282.30M	-0.25M	-303.60M	-299.60M	-0.34M		-319.86M	-323.45M	-326.30M	0.00M	-101.90M	-111.40M	-122.70M	-135.45M	0.10M
Preferred Shares (Quarter)

Research Tools

Palvella Therapeutics Balance Sheet (2013-2026) | PVLA

Create an account

Sign In

Reset Password